{"id":"W4390663037","doi":"10.1007/s40120-023-00570-w","title":"The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"F. Hoffmann-La Roche; Bristol-Myers Squibb","keywords":"Myostatin; Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Internal medicine; Clinical endpoint; Placebo; Endocrinology; Clinical trial; Skeletal muscle; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002341006,0.0001067391,0.0001508557,0.00001397472,0.000156998,0.000005923433,0.0001103434,0.0001232276,0.000004869868],"category_scores_gemma":[0.00002017872,0.00005627696,0.0001058384,0.00003326769,0.0003154753,0.000002194381,0.00001542933,0.00006045608,4.1068e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":8.425137e-7,"about_ca_system_score_gemma":0.00006163964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007469448,"about_ca_topic_score_gemma":0.00002696092,"domain_scores_codex":[0.9992065,0.0001417845,0.0002357172,0.0002464924,0.00003363592,0.0001358389],"domain_scores_gemma":[0.999416,0.0002397026,0.00005945098,0.0002264069,0.00003266642,0.00002579088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004805357,0.0008374753,0.00522935,0.00003847244,0.001076443,0.000003366858,0.0008915492,0.00008259246,0.2856661,0.001918842,0.0003399929,0.6991104],"study_design_scores_gemma":[0.00395407,0.01957215,0.1324264,0.00000693694,0.00009291493,0.00001637915,0.0001800761,0.0005909198,0.1129918,0.002360932,0.7275468,0.0002606181],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986269,0.01211761,0.0004605812,0.0005590543,0.0002793676,0.0002827515,0.00001054464,0.000005649541,0.00001546785],"genre_scores_gemma":[0.9876881,0.01168574,0.0001613917,0.0002479983,0.00009607532,0.00006114451,0.00002701376,0.00001120611,0.00002132372],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7272068,"threshold_uncertainty_score":0.2294908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02643587828799274,"score_gpt":0.326808358016509,"score_spread":0.3003724797285162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}